Literature DB >> 1740587

Comparison of human nasal mucosal secretion in vivo and in vitro.

J Mullol1, G D Raphael, J D Lundgren, J N Baraniuk, M Mérida, J H Shelhamer, M A Kaliner.   

Abstract

The secretion of proteins from the human nasal mucosa induced by histamine, alpha-adrenergic, beta-adrenergic, and cholinergic agonists was studied in vivo and in vitro. Glandular secretion of lactoferrin, lysozyme (in vivo only), and respiratory glycoconjugates (RGCs) was measured. Vascular permeability was determined in vivo by albumin secretion in relationship to the other proteins. Muscarinic stimulation by methacholine induced significant glandular secretion (lactoferrin, lysozyme and/or RCGs) both in vivo and in vitro, confirming that muscarinic receptors are stimulated directly. Histamine induced predominantly vascular permeability in vivo but caused some glandular secretion as well. However, in vitro, histamine had no effect on glandular secretion, suggesting that histamine acts predominantly on the nasal vascular bed and only affects glandular secretion through reflex actions. Phenylephrine, an alpha-adrenergic agonist, selectively stimulated lysozyme release in vivo, and both RGCs and lactoferrin release in vitro. Thus, alpha-adrenergic stimulation has some direct, albeit minimal, capacity to stimulate mucosal glands. beta-Adrenergic agonists had no effect on glandular secretion or vascular permeability either in vivo or in vitro. Therefore, glandular secretion is directly stimulated by alpha-adrenergic and cholinergic agonists, but not by beta-adrenergic agonists. The stimulation of glandular secretion by histamine is indirect and mediated through the action of neural reflexes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740587     DOI: 10.1016/0091-6749(92)90326-w

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

Review 1.  [Neural control of the respiratory nasal mucosa].

Authors:  S Knipping; A Riederer; A Berghaus
Journal:  HNO       Date:  2004-05       Impact factor: 1.284

Review 2.  Immunity, infection, and nasal disease.

Authors:  S H Yoshida; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  1998 Spring-Summer       Impact factor: 8.667

Review 3.  Neurology of allergic inflammation and rhinitis.

Authors:  Brendan J Canning
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

4.  Effect of ipratropium on nasal reactivity to histamine and eosinophil influx in perennial allergic rhinitis.

Authors:  P Górski; K Pazdrak; U Ruta
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 5.  Models for the study of nasal and sinus physiology in health and disease: A review of the literature.

Authors:  Ahmed A Al-Sayed; Remigius U Agu; Emad Massoud
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-10-31

Review 6.  Early humoral defence: Contributing to confining COVID-19 to conducting airways?

Authors:  Carl Persson
Journal:  Scand J Immunol       Date:  2021-02-07       Impact factor: 3.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.